DOVER, Del., April 1 /PRNewswire/ -- Extreme Physical Performance (EP2), a sport supplement firm, has partnered with INDUS BIOTECH -- a drug discovery company that manufactures a new generation of safe and effective ingredients that have been proven to show advancements in human physical performance. Together, they will bring innovative new products to the US market for bodybuilders and serious gym goers.
TORABOLIC is Indus's first new novel ingredient that EP2 will bring to market and will be branded as ANABEUTROL. TORABOLIC was clinically tested by Dr. Colin Wilborn at his Human Performance Lab at the
EP2's exclusive partnership with drug development company Indus Biotech has paved the way for the development of proprietary ingredients not found in any other supplement in the world. Recently, EP2 debuted ANABEUTROL, its clinically tested supplement that stimulates muscle growth, metabolism of fat and cell differentiation at an unprecedented rate. This year also saw the launch of the long-awaited ANDRITEST, bodybuilding's fastest bioactive testosterone amplifier.
About Extreme Physical Performance
Extreme Physical Performance (EP2) is a new sports supplement firm that develops muscle-building formulas designed to help you make remarkable advancements to your physique. By partnering with INDUS Biotech and using its proprietary and patented bioactive compounds, EP2 will develop cutting-edge products that are truly one of a kind and cannot be duplicated in any way. EP2's goal is to help you achieve Strength Beyond Muscle(TM).
|SOURCE Extreme Physical Performance|
Copyright©2009 PR Newswire.
All rights reserved